KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Payables (2016 - 2025)

Petmed Express' Payables history spans 15 years, with the latest figure at $20.3 million for Q4 2025.

  • For Q4 2025, Payables rose 85.47% year-over-year to $20.3 million; the TTM value through Dec 2025 reached $20.3 million, up 85.47%, while the annual FY2025 figure was $23.6 million, 36.35% down from the prior year.
  • Payables reached $20.3 million in Q4 2025 per PETS's latest filing, up from $19.1 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $40.0 million in Q2 2023 to a low of $10.9 million in Q4 2024.
  • Average Payables over 5 years is $24.6 million, with a median of $24.1 million recorded in 2022.
  • Peak YoY movement for Payables: soared 135.08% in 2023, then crashed 71.83% in 2024.
  • A 5-year view of Payables shows it stood at $21.9 million in 2021, then increased by 10.86% to $24.3 million in 2022, then skyrocketed by 59.77% to $38.9 million in 2023, then plummeted by 71.83% to $10.9 million in 2024, then skyrocketed by 85.47% to $20.3 million in 2025.
  • Per Business Quant, the three most recent readings for PETS's Payables are $20.3 million (Q4 2025), $19.1 million (Q3 2025), and $20.0 million (Q2 2025).